|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash and cash equivalents, current portion | ||||||||||||||||||||
| Marketable equity securities | ||||||||||||||||||||
| Marketable debt securities | ||||||||||||||||||||
| Restricted marketable equity securities | ||||||||||||||||||||
| Restricted marketable debt securities, current portion | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Notes receivable | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and Equipment: | ||||||||||||||||||||
| Property and equipment, at cost | ||||||||||||||||||||
| Accumulated depreciation and amortization | ||||||||||||||||||||
| Net property and equipment | ||||||||||||||||||||
| Other Assets: | ||||||||||||||||||||
| Restricted cash and cash equivalents, less current portion | ||||||||||||||||||||
| Restricted marketable debt securities, less current portion | ||||||||||||||||||||
| Deposits and other assets | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Investments in unconsolidated companies | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Trade accounts payable | ||||||||||||||||||||
| Finance lease obligations, current portion | ||||||||||||||||||||
| Operating lease liabilities, current portion | ||||||||||||||||||||
| Accrued payroll | ||||||||||||||||||||
| Amounts due to third party payors | ||||||||||||||||||||
| Accrued risk reserves, current portion | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Long-term debt, current portion | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Finance lease obligations, less current portion | ||||||||||||||||||||
| Total long-term debt, less current portion | ||||||||||||||||||||
| Operating lease liabilities, less current portion | ||||||||||||||||||||
| Accrued risk reserves, less current portion | ||||||||||||||||||||
| Refundable entrance fees | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Common stock, $.01 par value; 45,000,000 shares authorized; 15,661,395 and 15,536,427 shares, respectively, issued and outstanding | ||||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total National HealthCare Corporation stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
